Results 101 to 110 of about 87,895 (325)
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease [PDF]
, 2017 Capillary electrophoresis coupled with mass spectrometry (CE-MS) has been used as a platform for discovery and validation of urinary peptides associated with chronic kidney disease (CKD).
Mischak, Harald, Pontillo, Claudia
core +1 more source
Arthritis &Rheumatology, EarlyView.Objective A phase 2 trial tested different doses of the anti‐CD40 monoclonal antibody BI 655064 as an add‐on therapy to the standard of care in patients with class III or IV lupus nephritis (LN) with active disease. A post hoc analysis showed a potential benefit of the higher tested doses (180 and 240 mg) versus a low dose (120 mg) or placebo.
Martina Uzzo +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen +9 more
wiley +1 more source
, 2023 The Laryngoscope, Volume 133, Issue 1, Page 2-3, January 2023.
Craig S. Derkay +9 more
wiley +1 more source
Albuminuria and Cylindruria [PDF]
The American Journal of the Medical Sciences, 1912 n ...
openaire +1 more source
Correlates of calcaneal quantitative ultrasound parameters in patients with diabetes: the study on the assessment of determinants of muscle and bone strength abnormalities in diabetes [PDF]
, 2017 OBJECTIVE: Quantitative ultrasound (QUS) provides an estimate of bone mineral density (BMD) and also evaluates bone quality, which has been related to increased fracture risk in people with diabetes.
Alessi, Elena +11 more
core +2 more sources
Albuminuria and Eclampsia [PDF]
The American Journal of the Medical Sciences, 1896 n ...
openaire +1 more source
Cancer Communications, EarlyView.Abstract Background The prognosis for non‐small cell lung cancer (NSCLC) patients treated with standard platinum‐based chemotherapy was suboptimal, with safety concerns. Following encouraging results from a preliminary phase I study, this phase II trial investigated the efficacy and safety of first‐line sintilimab and anlotinib in metastatic NSCLC ...
Tianqing Chu +13 more
wiley +1 more source